FDA Inspection
VitalantVitalant – FDA Inspection, Dec 9, 2013
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on December 9, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- December 9, 2013
- Product Type
- Biologics
View Company Profile
ID · 25f79a2d-224f-4b73-92b7-6586f5b44734
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 858500
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 14, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 22, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1256872 - 2024-12-05
- FDA Inspection 1180193 - 2022-09-14
- FDA Inspection 1033943 - 2017-11-28
- FDA Inspection 958203 - 2016-01-25
- FDA Inspection 783582 - 2012-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.